Accéder au contenu
Merck

Improvement of XTT assay performance for studies involving Candida albicans biofilms.

Brazilian dental journal (2009-01-31)
Wander José da Silva, Jayampath Seneviratne, Nipuna Parahitiyawa, Edvaldo Antonio Ribeiro Rosa, Lakshman Perera Samaranayake, Altair Antoninha Del Bel Cury
RÉSUMÉ

2, 3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) reduction assay has been used to study Candida biofilm formation. However, considering that the XTT reduction assay is dependent on cell activity, its use for evaluating mature biofilms may lead to inaccuracies since biofilm bottom cell layers tend to be relatively quiescent at later stages of biofilm formation. The aim of this study was to improve XTT reduction assay by adding glucose supplements to the standard XTT formulation. Candida albicans ATCC 90028 was used to form 24-, 48- and 72-h biofilms. The oxidative activity at 90, 180 and 270 min of incubation was evaluated. The control consisted of standard XTT formulation without glucose supplements, and was modified by the addition of 50, 100 and 200 mM of glucose. The XTT assay with 200 mM glucose showed more accurate and consistent readings correlating with biofilm development at 24, 48 and 72 h. Biofilm growth yield after 180 min incubation, when evaluated with the 200 mM glucose supplemented XTT, produced the most consistent readings on repetitive testing. It may be concluded that glucose supplementation of XTT could minimize variation and produce more accurate data for the XTT assay.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
XTT sodium salt, powder, BioReagent, suitable for cell culture